Loading
Latest filing published 22 Apr 2019 for Clementia Pharmaceuticals Inc., €974k.
No signal scores available.
Allan Mandelzys discloses dealings in Clementia Pharmaceuticals Inc. to SEDI. The record holds 2 filings, for trades running from 14 August 2017 to 17 April 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 22 April 2019, the filings show a transaction worth €974k in Clementia Pharmaceuticals Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations